baber/WOPTO huggingface dataset:
Patent EP-2353104-A2 (EP)
Title: Modélisation d'identités de parties dans des systèmes de stockage informatiques
Inventor: SHORT KEITH W
IPC: G06F17/00
Filed: 2009-10-16
Abstract: La présente invention concerne des procédés, systèmes et produits de programme informatique permettant la modélisation des identités de partie dans les systèmes de stockage informatique. Une structure d’identité fédérée modélise les données d’identité et les relations entre parties de données d’identité dans des systèmes de stockage informatique conformément à un schéma uniforme. La structure d’identité fédérée peut fédérer des données distribuées d’identité et de relations d’identités provenant de systèmes de stockage informatique à l’intérieur d’une diversité d’environnements informatiques différents. Les codes et métadonnées d’environnements informatiques associés à la structure d’identité fédérée peuvent interagir pour faciliter l’uniformité du stockage, de l’accès, de la modification, de la suppression et de la sécurisation des données d’identité et de relations des identités à l’intérieur de la structure d’identité fédérée. Les modes de réalisation de la présente invention concernent l’utilisation d’une entrée de table de clé d’identité pour localiser les informations d’identité d’une partie, et l’exécution de transformations de clé entre différents types de clé d’identité.
Patent EP-2305642-A2 (EP)
Inventor: KOSTIK ELENA
IPC: A61P35/00
Filed: 2005-06-20
Abstract: Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I) 
 
         2 M +  or M 2+       Y is a covalent bond or a substituted or unsubstituted straight chained hydrocarbyl group. R 1 -R 4  are independently -H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group, or R 1  and R 3  taken together with the carbon and nitrogen atoms to which they are bonded, and/or R 2  and R 4  taken together with the carbon and nitrogen atoms to which they are bonded, form a non-aromatic heterocyclic ring optionally fused to an aromatic ring. Z is -O or -S. M +  is a pharmaceutically acceptable monovalent cation and M 2+  is a pharmaceutically acceptable divalent cation. Also disclosed are pharmaceutical compositions comprising a bis(thio-hydrazide amide) disalt described above. Further disclosed are methods of treating a subject with cancer. The methods comprise the step of administering an effective amount of a bis(thio-hydrazide amide) disalt.
Patent EP-2308427-A2 (EP)
Inventor: BORT WOLFGANG
IPC: A61F5/02
Filed: 2010-09-17
Abstract: An orthopedic orthosis (10) for bracing body region of patient, comprises sensor contrivance (1) for sensing motion of body region, where orthosis comprises resiliently deformable sensor portion disposed on orthosis such that movement of body region causes resilient deformation of sensor portion, where contrivance has actor for coupling waves into sensor portion and sensor for detecting waves coupled into portion, where actor and sensor are disposed on portion such that sensor can sense wave which is coupled into portion by actor and has been changed according to deformation of portion. An orthopedic orthosis (10) for bracing a body region of a patient, comprises at least one sensor contrivance (1) provided for sensing the motion of the body region, where the orthosis comprises at least one resiliently deformable sensor portion, which is disposed on the orthosis such that a movement of the body region causes resilient deformation of the sensor portion, where the sensor contrivance has at least one actor for coupling waves into the sensor portion and at least one sensor for detecting the waves coupled into the sensor portion, where the actor and the sensor in the sensor contrivance are disposed on the sensor portion such that the sensor can sense the wave which has been coupled into the sensor portion by the actor and has been changed according to the deformation of the sensor portion. The orthosis has at least one main portion (20) which surrounds the body region such that a movement of the body region causes deformation of the main portion, and the sensor portion is formed at least in part as an integral part of the main portion and/or the sensor portion is formed at least in part by a supplementary portion mounted on the main portion. The main portion is a part made of plastics material, particularly a part made of polyethylene and/or the supplementary portion is made of fiber-reinforced compound material. The orthosis is in the form of a spinal orthosis having at least one back portion disposed in the back region of the patient and at least one pair of wing-like portions (24a, 24b) connected to the back portion and the pair of wing-like portions consists of two wing-like portions which are provided opposite to each other on each side of the back portion and are bent around the opposite side of the body to extend to the region of the chest and/or abdomen, and sensor contrivances is provided which are adapted to detect changes in length or states of stress in the orthopedic orthosis, and at least one sensor contrivance of a first type is disposed on the back portion at the level of the pair of wing-like portions or on one of the wing-like portions, and at least one sensor contrivance of a second type is disposed on the back portion below or above the pair of wing-like portions.
Patent EP-2314612-A2 (EP)
Title: Differential in tumour gene products and use of same
Inventor: SAHIN UGUR
IPC: C12N15/113
Filed: 2003-03-12
Abstract: A pharmaceutical composition containing an agent (A) that: (a) inhibits expression or activity of a tumor-associated antigen (TAg); (b) has selective tumor-inhibiting activity against cells with (abnormal) expression of TAg; or (c) increases the amount of complex formed between an HLA (human leukocyte antigen) molecule and TAg, or its fragment, is new. A pharmaceutical composition containing an agent (A) that: (a) inhibits expression or activity of a tumor-associated antigen (TAg); (b) has selective tumor-inhibiting activity against cells with (abnormal) expression of TAg; or (c) increases the amount of complex formed between an HLA (human leukocyte antigen) molecule and TAg, or its fragment. TAg is encoded by nucleic acid (NA) that: (a) comprises any of 28 defined sequences given in the specification, or their fragments; (b) can hybridize to (a) under stringent conditions; (c) is a degenerate version of (a) or (b); or (d) is complementary to (a)-(c). Independent claims are also included for: (1) a pharmaceutical composition containing one or more of TAg, NA encoding TAg, antibody that binds to TAg, antisense sequences specific for NA, host cells that express TAg, or isolated complex of TAg with an HLA molecule (TAg may always by a fragment); (2) diagnosing diseases associated with (abnormal) expression of TAg (M1); (3) determining regression, progression or outbreak of diseases associated with (abnormal) expression of TAg (M2); (4) treating diseases associated with (abnormal) expression of TAg (M3); (5) NA as new compounds; (6) a nucleic acid (NA1) that encodes any of 35 specified peptide sequences or their fragments; (7) a recombinant DNA or RNA (NA2) that includes NA or NA1; (8) a host cell containing NA, NA1 or NA2; (9) proteins encoded by NA1 and their fragments that are immunogenic or can bind to HLA receptors or human antibodies; (10) agents (B) that bind specifically to a protein encoded by NA; (11) antibodies (Ab) that bind specifically to a complex of: (a) protein or its fragments encoded by NA; and (b) Major Histocompatibility (MHC) molecules to which (a) bind, but does not bind to (i) or (ii) singly; (12) a conjugate (C) between (B) or Ab and a diagnostic or therapeutic agent; (13) a kit for detecting (abnormal) expression of TAg; (14) recombinant DNA that includes a promoter region derived from NA; and (15) treatment, diagnosis and monitoring of metastatic cancer associated with (abnormal) expression of TPTE. ACTIVITY : Cytostatic. No biological data given. MECHANISM OF ACTION : Vaccine; Antisense/antibody inhibition of gene expression or activity.
Patent EP-2275126-A2 (EP)
Inventor: MIZRACHI NEBENZAHL YAFFA
IPC: A61K39/00
Filed: 2003-04-01
Abstract: The invention relates to a vaccine composition comprising as an active ingredient an effective amount of an isolated  S. pneumoniae  PTS system, mannose-specific IIAB components (PTS, Accession No. NP_344822), optionally together with one or more pharmaceutically acceptable adjuvant(s).
Patent EP-2218980-A2 (EP)
Inventor: HENDRIK MEYER
IPC: F24S50/20
Filed: 2010-02-11
Abstract: The device (24) has a reflector (14) arranged adjacent to a solar panel (3) arranged in direct sunlight (11) such that the sunlight is reflected on an active surface of the panel at a rotating position. A controller (20) controls a actuator (19) depending on sun's altitude such that either the light that is reflected from the reflector to the active surface completely covers the active area in a supporting mode or no sunlight reflection from the reflector to the active area takes place in a passive mode if holohedral illumination of the active area is not possible. An independent claim is also included for a method for supporting generation of energy from sunlight by solar panels.
Patent EP-2275966-A2 (EP)
Inventor: DAVIS GLEN W
IPC: G06K7/14
Filed: 1999-09-14
Abstract: A variety of complementary methodologies may be selectively and systematically employed and are capable of reconstructing label information, such as undecodable characters or elements, where label (95) defects may prevent decoding. Such methodologies include reconstruction from partial information ( Figure 2 ), use of edge strength indicators ( Figure 4 ), decoding techniques based on agressiveness, and learning mode for agressiveness level. Distortion of label information due to mechanical aspects of the scanning mechanism may be corrected and feedback from decoding may be used to adapt various signal processing parameters, such as gain and threshold. Decoding of a digital representation of an input signal may be attempted at first with decoding of the part or all of analog signal being undertaken only after a number of attempts at the digital signal prove unsuccessful.
Patent EP-2272546-A2 (EP)
Inventor: BAYER ULLRICH
IPC: A61L31/02
Filed: 2010-06-18
Abstract: The method involves providing a body of an implant, and manufacturing a partially closed pore structure in a part of the upper surface closed structure of the implant body. The nitrogen oxide is provided in the hollow space of the pore structure. The upper structure of the implant body has a cover which is made of polymer containing parylene. An independent claim is also included for an implant with pores.
Patent EP-2270197-A2 (EP)
Inventor: GERBER DAVID J
IPC: C12Q1/68
Filed: 2003-03-26
Abstract: The present invention provides targets, methods, and reagents for the diagnosis and treatment of schizophrenia and related conditions. The invention provides methods for the diagnosis of schizophrenia and susceptibility to schizophrenia by detection of polymorphisms, mutations, variations, alterations in expression, etc., in calcineurin genes or calcineurin interacting genes, or polymorphisms linked to such genes. The invention provides oligonucleotides, arrays, and antibodies for detection of polymorphisms and variants. The invention provides transgenic mice having alterations in such genes. The invention also provides methods of treating schizophrenia by administering compounds that target these genes. The invention further provides screening methods for identifying such compounds and compounds obtained by performing the screens.
Patent EP-2317102-A2 (EP)
Inventor: TOYOHARA MASAHIRO
IPC: F02D41/14
Filed: 2010-08-17
Abstract: A fuel injection control apparatus for an internal combustion engine which can inject a fuel injection quantity to a fuel injector with accuracy even when the fuel injection quantity is reduced than before is provided. A fuel injection control apparatus of a direct cylinder injection type of internal combustion engine, including a fuel injector which performs fuel injection by supplying a drive current to a solenoid, a fuel pressure sensor which detects fuel pressure supplied to the fuel injector, and operation state detecting means which detects the operation state of the internal combustion engine, comprises current profile changing means 100 which has multiple current profiles of the drive current and changes current profiles based on the operation state and the fuel pressure, valid pulse width calculating means 701 which calculates a valid pulse width for opening and driving the fuel injector, invalid pulse width calculating means 103 which calculates an invalid pulse width, and fuel injector control means which calculates a fuel injection pulse width based on the valid pulse width and the invalid pulse width, and controls the fuel injector based on the fuel injection pulse width, wherein the invalid pulse width calculating means 103 calculates an invalid pulse width corresponding to the current profiles to be changed before the current profiles are changed.
Patent EP-2299708-A2 (EP)
Inventor: SMITH DAVID
IPC: H04N7/167
Filed: 2010-09-07
Abstract: A system is provided comprising a key memory storing a group of keys for use in decryption. The system further comprises a programmable memory configured to store a set of rules governing access to the key memory and a first engine for deriving a first key using a second key from said key group. The engine is configured to transmit a request for access to the second key from the key memory. The system further comprises logic connected between the engine and the key memory and further connected to the programmable memory. The logic is configured to receive the request from the engine and to use the set of rules to control the access to the second key in the key memory. The programmable memory is writeable in situ to replace said set of rules with an alternative set of rules.
Patent EP-2289311-A2 (EP)
Inventor: STEINER HENRY-YORK
IPC: A01H5/00
Filed: 2005-02-16
Abstract: A novel transgenic corn event designated MIR604, is disclosed. The invention relates to DNA sequences of the recombinant constructs inserted into the corn genome and of genomic sequences flanking the insertion site that resulted in the MIR604 event. The invention further relates to assays for detecting the presence of the DNA sequences of MIR604, to corn plants and corn seeds comprising the genotype of MIR604 and to methods for producing a corn plant by crossing a corn plant comprising the MIR604 genotype with itself or another corn variety
Patent EP-2259534-A2 (EP)
Inventor: DOELLE THOMAS
IPC: H04L7/00
Filed: 1997-11-05
Abstract: According to the present invention a system and a method for synchronising digital communication systems is proposed. Thereby a reference symbol RS consisting of a sequence of a plurality of synchronisation patterns SP and followed by data symbols, which are both modulated (13) on a RF-frequency is provided. The received reference symbol (RS) is correlated with a delayed version of itself and the correlation peak is identified giving the position and complex correlation result that can be used for the timing and frequency synchronisation of a digital communication system. According to the present invention the phase of the last and/or the first of the plurality of synchronisation patterns SP of said reference symbol RS (or a part or a multiple thereof) is phase shifted, e.g. by 180°, before the transmission step. According to the present invention therefore the effects of random contribution of adjacent data symbols of the reference symbol to a correlation calculation based on a synchronisation algorithm can be entirely eliminated. Through the inversion of the last synchronisation pattern and the reference symbol the correlation peak, which is used to determine the symbol timing, is offset inside the reference symbol. Thus, the precision of the timing error estimation is improved significantly.
Patent EP-2260722-A2 (EP)
Inventor: HOLAHAN JOHN
IPC: A61K49/04
Filed: 2002-08-02
Abstract: Use of an aqueous thickener concentrate to reduce the preparation time of a beverage by admixing said aqueous thickener concentrate with said beverage.
Patent EP-2309009-A2 (EP)
Inventor: OTT ERIC ALLEN
IPC: C22C1/00
Filed: 2005-05-11
Abstract: A method for preparing an article of a base metal alloyed with an alloying element includes the steps of preparing a compound mixture by the steps of providing (40) a chemically reducible nonmetallic base-metal precursor compound of a base metal, providing (42) a chemically reducible nonmetallic alloying-element precursor compound of an alloying element, and thereafter mixing (44) the base-metal precursor compound and the alloying-element precursor compound to form a compound mixture. The compound mixture is thereafter reduced (48) to a metallic alloy, without melting the metallic alloy. The step of preparing or the step of chemically reducing includes the step of adding an other additive constituent. The metallic alloy is thereafter consolidated to produce a consolidated (50) metallic article, without melting the metallic alloy and without melting the consolidated metallic article.
Patent EP-2238990-A2 (EP)
Inventor: MAKABE MIKI
IPC: A61L15/58
Filed: 2010-04-07
Abstract: Provided are a patch and a patch preparation having an adhesive layer on at least one surface of a support, and particularly, a patch and a patch preparation superior in skin adhesive force, and causing less adhesive residue on the skin surface. A patch having a support and an adhesive layer formed on at least one surface of the support, wherein the adhesive layer contains an elastomer obtained by crosslinking a polymer having a butadiene skeleton in the presence of an organic peroxide, and the ratio of the weight of a toluene-insoluble component in the adhesive layer to the total weight of the adhesive layer is 5 - 32 wt%.
Patent EP-2563507-A2 (EP)
Title: Particules de distribution
Inventor: DIHORA JITEN ODHAVJI
IPC: C09K23/52
Filed: 2010-05-12
Abstract: L'invention concerne des agents bénéfiques encapsulés, des compositions comprenant les agents bénéfiques encapsulés et des procédés de production et d'utilisation des compositions comprenant lesdits agents bénéfiques encapsulés. Ces agents bénéfiques permettent d'éliminer ou de limiter un ou plusieurs inconvénients des agents bénéfiques encapsulés actuels et donc d'utiliser des formulateurs à possibilités de distribution de parfum supplémentaires.
Patent EP-2415194-A2 (EP)
Inventor: CAI ZHIJUN
IPC: H04L5/00
Filed: 2010-03-30
Abstract: La présente invention concerne un procédé permettant d'assurer une transmission de demande de retransmission automatique hybride (HARQ) pendant la réaffectation d'une porteuse de composant (CC). Le procédé consiste à lancer un processus HARQ à l'aide d'une première CC, à affecter une seconde CC, à mapper le processus HARQ de la première CC à la seconde CC et à transmettre les données HARQ restantes associées au processus HARQ à l'aide de la seconde CC. La présente invention concerne également un procédé permettant d'assurer une transmission HARQ qui consiste à lancer un processus HARQ à l'aide d'une première CC, à déterminer l'affectation d'une seconde CC, à attendre jusqu'à ce que le processus HARQ soit terminé à l'aide de la première CC, avant d'affecter la seconde CC et à commencer un autre processus HARQ sur la seconde CC. L'invention concerne également un procédé qui consiste à lancer un processus HARQ à l'aide d'une première CC, à affecter une seconde CC, à interrompre la transmission à l'aide de la première CC avant l'achèvement du processus HARQ et à redémarrer la transmission de nouvelles données à l'aide de la seconde CC.
Patent EP-2445934-A2 (EP)
Title: Polypeptides multimères de hla-g comprenant au moins deux domaines alpha3 et leurs utilisations pharmaceutiques
Inventor: LE MAOULT JOEL
IPC: A61P37/06
Filed: 2010-06-25
Abstract: Cette invention concerne des polypeptides multimères et leurs utilisations pharmaceutiques; des multimères comprenant des peptides alpha3 dun antigène HLA-G et des méthodes de production de ces multimères, des compositions pharmaceutiques comprenant ces composés, ainsi que leurs utilisations pour traiter différentes maladies, notamment le rejet dorgane/de tissu. Lesdits multimères comprennent au moins deux monomères, chacun desdits monomères étant choisis dans le groupe constitué par un peptide Pl de formule X1 -X2, X1 représentant un lieur peptidique, notamment la cystéine, et X2 un domaine alpha3 de HLA-G.
Patent EP-2473164-A2 (EP)
Title: Antimikrobielle etherguanidine
Inventor: SPRINGER OLIVER
IPC: A61K31/155
Filed: 2010-07-19
Abstract: Gegenstand der Erfindung ist die Verwendung mindestens eines Etherguanidins der allgemeinen Formeln (I) und/oder seines Salzes oder Hydrates, in dem R 1  = -CH 2 -CH 2 -CH 2 -O-R 3  mit R 3  linearer oder verzweigter Kohlenwasserstoffrest mit 6 bis 22 Kohlenstoffatomen, und R 2  = H oder ein gegebenenfalls verzweigter, gegebenenfalls Doppelbindungen enthaltender Kohlenwasserstoffrest mit 1 bis 22 C-Atomen, ist zur Reduktion des Wachstums von Mikroorganismen, sowie kosmetische und pharmazeutische Formulierungen enthaltend mindestens ein Etherguanidin der allgemeinen Formeln (I).
Patent EP-2456680-A2 (EP)
Title: Dispositif-contenant revêtu et procédé permettant sa réalisation
Inventor: KAINZ BERNHARD
IPC: B65D25/14
Filed: 2010-07-23
Abstract: La présente invention concerne un dispositif-contenant revêtu et un procédé permettant sa réalisation. Le dispositif-contenant revêtu selon l'invention comprend : (1) un substrat métallique; et (2) une ou plusieurs couches de revêtement associées au substrat métallique, la ou les couches de revêtement résultant de l'application d'une ou de plusieurs dispersions aqueuses sur au moins une surface du substrat métallique, et la ou les dispersions aqueuses comprenant (a) un ou plusieurs polymères de base, (b) un ou plusieurs agents stabilisants, (c) éventuellement un ou plusieurs agents neutralisants et (d) de l'eau.
Patent EP-2470156-A2 (EP)
Inventor: MIJOLOVIC DARIJO
IPC: A61K8/34
Filed: 2010-08-16
Abstract: The invention discloses the use of a diol as a biocidal substance, characterised in that said use relates to a diol of formula (I), in which R1 and R2, independently of one another represent an organic group each having at least one C atom, or in which R1 and R2 together form a ring system that consists of at least 4 C atoms, and optionally can be substituted if required (referred to hereafter simply as 1,3-diol).
Patent EP-2460195-A2 (EP)
Inventor: STEFAN MADALINA ANDREEA
IPC: H01L35/34
Filed: 2010-07-23
Abstract: L'invention concerne l'utilisation de fours à induction pour la fabrication de branches thermoélectriques et d'unités de construction pour modules thermoélectriques ainsi qu'un procédé de fabrication de matériaux semi-conducteurs thermoélectriques par fusion de mélanges des constituants élémentaires des matériaux semi-conducteurs thermoélectriques ou de leurs alliages dans un four à induction et par coulée de la fonte ainsi obtenue sous la forme d'une branche thermoélectrique ou pulvérisation de la fonte ainsi obtenue pour la fabrication d'un matériau semi-conducteur thermoélectrique pulvérulent.
Patent EP-2485847-A2 (EP)
Inventor: MOLZ RONALD J
IPC: B05B1/08
Filed: 2010-08-18
Abstract: L'invention concerne un appareil et un procédé destinés à préparer une surface d'un alésage de cylindre à l'aide d'un jet d'eau pulsé, faisant intervenir des étapes consistant à générer un signal de fréquence f à l'aide d'un générateur de signal, à appliquer le signal pour générer un jet d'eau pulsé à travers un orifice de sortie d'une buse présentant un diamètre d d'orifice de sortie et une longueur L. Le jet d'eau pulsé prépare la surface de manière à l'amener dans les limites d'une gamme prédéterminée d'état de surface. Ledit état de surface est déterminé en sélectionnant des paramètres de fonctionnement comprenant une distance de garde (standoff distance, SD), une vitesse de défilement V TR  de la buse, une pression d'eau P, un débit d'eau Q, un rapport longueur-diamètre (L/d), la fréquence f et une amplitude A du signal.